Clélia Orange

Clélia Orange has a diverse background in project management within the biotech and healthcare sectors. Clélia is currently working as a Global Project Leader at SparingVision since 2022. Prior to this, Clélia worked at ELSALYS BIOTECH from 2016 to 2022, where they served as a Project Leader. In this role, they managed a program focused on the commercialization of a monoclonal antibody for the treatment of an orphan disease, as well as overseeing the development of an innovative antibody for retinal vascular disease. Clélia also held the position of R&D Project Manager at CLARA - Cancéropôle Lyon Auvergne Rhône-Alpes from 2013 to 2016, where they identified and managed various promising cancer research projects. Additionally, they have experience as a Project Leader at Transgene from 2008 to 2012, coordinating multidisciplinary teams in the field of oncology. Clélia's earlier career includes a role as a Research Project Manager at Université Louis Pasteur, Strasbourg from 2003 to 2007, where they led a study on actin cytoskeleton proteins. Overall, Clélia brings extensive project management experience in the biotech and healthcare industries.

Clélia Orange began their education in 1998 at Université Savoie Mont Blanc, where they pursued a DEUG degree in Life Science. Clélia then continued their studies at Université Louis Pasteur (Strasbourg I) from 2000 to 2003, earning a Magistère degree in Chemistry-Biology. Clélia went on to attend Université de Strasbourg (formerly Université Louis Pasteur - Strasbourg 1) from 2003 to 2007, completing a PhD in Molecular and Cellular Aspects of Biology. Lastly, from 2007 to 2008, Clélia attended EM Strasbourg Business School, where they obtained a Master's degree in Management of innovative projects.